Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Name: Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
SKU: 2991
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 2 Articles Tags: alok-krishen, antidepressants, brenda-d-jamerson, chb, domains, jack-g-modell, jeremy-roberts, k-ranga-rama-krishnan, pharmd, principal-component-analysis, psychometrics, symptom-clusters

Description

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression

Judith J. Wurtman, PhD: The Effect of a Novel Dietary Intervention on Weight Loss in Psychotropic Drug-Induced Obesity

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

Related products

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression

Judith J. Wurtman, PhD: The Effect of a Novel Dietary Intervention on Weight Loss in Psychotropic Drug-Induced Obesity

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology